Protalix BioTherapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PLX and other ETFs, options, and stocks.

About PLX

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. 

CEO
Dror Bashan
CEODror Bashan
Employees
226
Employees226
Headquarters
Hackensack, New Jersey
HeadquartersHackensack, New Jersey
Founded
1993
Founded1993
Employees
226
Employees226

PLX Key Statistics

Market cap
160.74M
Market cap160.74M
Price-Earnings ratio
10.69
Price-Earnings ratio10.69
Dividend yield
Dividend yield
Average volume
744.91K
Average volume744.91K
High today
$2.02
High today$2.02
Low today
$1.92
Low today$1.92
Open price
$1.95
Open price$1.95
Volume
460.11K
Volume460.11K
52 Week high
$3.19
52 Week high$3.19
52 Week low
$1.32
52 Week low$1.32

Stock Snapshot

As of today, Protalix BioTherapeutics(PLX) shares are valued at $2.00. The company's market cap stands at 160.74M, with a P/E ratio of 10.69.

On 2026-06-04, Protalix BioTherapeutics(PLX) stock traded between a low of $1.92 and a high of $2.02. Shares are currently priced at $2.00, which is +3.7% above the low and -1.2% below the high.

Protalix BioTherapeutics(PLX) shares are trading with a volume of 460.11K, against a daily average of 744.91K.

In the last year, Protalix BioTherapeutics(PLX) shares hit a 52-week high of $3.19 and a 52-week low of $1.32.

In the last year, Protalix BioTherapeutics(PLX) shares hit a 52-week high of $3.19 and a 52-week low of $1.32.

People also own

Based on the portfolios of people who own PLX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.